Neurocrine Biosciences
NBIX
#1506
Rank
โ‚น995.53 B
Marketcap
โ‚น9,985
Share price
-3.57%
Change (1 day)
-9.46%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

EPS for Neurocrine Biosciences (NBIX)

EPS in 2023 (TTM): โ‚น162.41

According to Neurocrine Biosciences 's latest financial reports the company's current EPS (TTM) is โ‚น170.95. In 2022 the company made an earnings per share (EPS) of โ‚น140.42 an increase over its 2021 EPS that were of โ‚น82.86.

EPS history for Neurocrine Biosciences from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น162.4115.65%
2022โ‚น140.4269.47%
2021โ‚น82.86-78.21%
2020โ‚น380.28990%
2019โ‚น34.8981.82%
2018โ‚น19.19-113.5%
2017-โ‚น142.170.62%
2016-โ‚น141.3057.28%
2015-โ‚น89.8425.61%
2014-โ‚น71.5218.84%
2013-โ‚น60.18-1085.71%
2012โ‚น6.11-89.71%
2011โ‚น59.31-500%
2010-โ‚น14.83-86.92%
2009-โ‚น113.39-43.48%
2008-โ‚น200.61-57.8%
2007-โ‚น475.3592.58%
2006-โ‚น246.83371.67%
2005-โ‚น52.33-52.76%
2004-โ‚น110.7736.56%
2003-โ‚น81.11-70%
2002-โ‚น270.38118.31%
2001-โ‚น123.858.4%
2000-โ‚น114.2648.86%
1999-โ‚น76.75-20%
1998-โ‚น95.94-479.31%
1997โ‚น25.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น182.29 6.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น47.97-71.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
-โ‚น258.17-251.02%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น473.54 177.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น321.03 87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น162.23-5.10%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น40.99-123.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น264.28-254.59%๐Ÿ‡บ๐Ÿ‡ธ USA